183 related articles for article (PubMed ID: 36574196)
1. Central diabetes insipidus with anti-rabphilin-3A antibody positivity causing hypovolemic shock after resection of tumorous lesions in the pelvic cavity.
Ohashi A; Takeda Y; Watada M; Ihara F; Oshita T; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Maeda Y
CEN Case Rep; 2023 Aug; 12(3):297-303. PubMed ID: 36574196
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy.
Sakurai K; Yamashita R; Niituma S; Iwama S; Sugimura Y; Arihara Z; Takahashi K
Endocr J; 2017 Jun; 64(6):645-650. PubMed ID: 28420857
[TBL] [Abstract][Full Text] [Related]
3. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus.
Kume Y; Sakuma H; Sekine H; Sumikoshi M; Sugimura Y; Hosoya M
Clin Pediatr Endocrinol; 2021; 30(1):65-69. PubMed ID: 33446956
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytic Infundibuloneurohypophysitis Diagnosis Owing to Positive Anti-rabphilin-3A Antibody Test Result in an 8-year-old Boy with Early-onset Central Diabetes İnsipidus.
Shoji Y; Naruse Y; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Mori M; Hiramoto R
J Clin Res Pediatr Endocrinol; 2023 Sep; ():. PubMed ID: 37743662
[TBL] [Abstract][Full Text] [Related]
6. Absence of anti-rabphilin-3A antibodies in children and young adults with idiopathic central diabetes insipidus: a potential clue to elucidating a tumor etiology.
Fujisawa H; Takeuchi T; Ishii A; Muto J; Kamasaki H; Suzuki A; Sugimura Y
Hormones (Athens); 2023 Dec; 22(4):747-758. PubMed ID: 37697216
[TBL] [Abstract][Full Text] [Related]
7. Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center.
Arihara Z; Sakurai K; Niitsuma S; Sato R; Yamada S; Inoshita N; Iwata N; Fujisawa H; Watanabe T; Suzuki A; Takahashi K; Sugimura Y
Sci Rep; 2022 Mar; 12(1):4440. PubMed ID: 35292721
[TBL] [Abstract][Full Text] [Related]
8. Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.
Iwama S; Sugimura Y; Kiyota A; Kato T; Enomoto A; Suzuki H; Iwata N; Takeuchi S; Nakashima K; Takagi H; Izumida H; Ochiai H; Fujisawa H; Suga H; Arima H; Shimoyama Y; Takahashi M; Nishioka H; Ishikawa SE; Shimatsu A; Caturegli P; Oiso Y
J Clin Endocrinol Metab; 2015 Jul; 100(7):E946-54. PubMed ID: 25919460
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune diabetes insipidus.
Scherbaum WA
Handb Clin Neurol; 2021; 181():193-204. PubMed ID: 34238458
[TBL] [Abstract][Full Text] [Related]
10. A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity.
Morota K; Tadokoro H; Sawano K; Watanabe K; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Nagasaki K
J Pediatr Endocrinol Metab; 2022 May; 35(5):687-690. PubMed ID: 35119230
[TBL] [Abstract][Full Text] [Related]
11. Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.
Deligiorgi MV; Siasos G; Vergadis C; Trafalis DT
Int Immunopharmacol; 2020 Jun; 83():106427. PubMed ID: 32244049
[TBL] [Abstract][Full Text] [Related]
12. Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report.
Zhou W; Rao J; Li C
BMC Endocr Disord; 2019 Dec; 19(1):143. PubMed ID: 31856773
[TBL] [Abstract][Full Text] [Related]
13. Permanent central diabetes insipidus after traumatic brain injury. Case report and literature review.
Astafyeva LI; Sidneva YG; Badmaeva IN; Kalinin PL; Latyshev YA; Marshintsev AV; Valiullina SA
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):112-118. PubMed ID: 36252201
[TBL] [Abstract][Full Text] [Related]
14. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Takahashi Y; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Nishimura H; Kimura H; Suzuki M; Konno S; Shimizu A; Matsuno Y; Okamoto M; Motegi H; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Miyoshi H; Atsumi T
Pituitary; 2022 Apr; 25(2):321-327. PubMed ID: 35088194
[TBL] [Abstract][Full Text] [Related]
16. Central diabetes insipidus caused by a pituitary stalk germinoma resembling infundibuloneurohypophysitis.
Dias D; Vilar H; Passos J; Leite V
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32912882
[TBL] [Abstract][Full Text] [Related]
17. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
Non L; Brito D; Anastasopoulou C
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Central Diabetes Insipidus in Adults.
Tomkins M; Lawless S; Martin-Grace J; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2022 Sep; 107(10):2701-2715. PubMed ID: 35771962
[TBL] [Abstract][Full Text] [Related]
19. Transient polyuria related to central diabetes insipidus caused by lymphocytic infundibulo-neurohypophysitis in a patient treated for Graves' disease.
Yamazaki M; Sato A; Nishio S; Uehara T; Komatsu M
Intern Med; 2010; 49(17):1885-90. PubMed ID: 20823651
[TBL] [Abstract][Full Text] [Related]
20. A Case of Lymphocytic Infundibulo-neurohypophysitis Exhibiting Spontaneous Regression.
Hasebe M; Shibue K; Honjo S; Hamasaki A
JCEM Case Rep; 2023 Mar; 1(2):luad020. PubMed ID: 37908468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
